SCHEMBL4743450

SCHEMBL4743450

C=CCC1Cc2c(C)cccc2C1=O

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ACHE P22303 3/20 0.55
METAP1 P53582 3/20 0.40
CYP19A1 P11511 4/20 0.39
HTR2A P28223 1/20 0.37
HTR2C P28335 1/20 0.37
HTR2B P41595 1/20 0.37
PARP1 P09874 1/20 0.36
PARP10 Q53GL7 1/20 0.36
PARP11 Q9NR21 1/20 0.36
AADAT Q8N5Z0 1/20 0.33
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
CA7 P43166 1/20 0.32
CA9 Q16790 1/20 0.32
ABCB1 P08183 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8873660 0.86 ACHE (0.57) ACHEMETAP1CYP19A1HTR2AHTR2C
SCHEMBL8598439 0.86 ACHE (0.57) ACHEMETAP1CYP19A1HTR2AHTR2C
SCHEMBL8595669 0.84 ACHE (0.54) ACHEMETAP1CYP19A1HTR2AHTR2C
SCHEMBL8874770 0.84 ACHE (0.54) ACHEMETAP1CYP19A1HTR2AHTR2C
SCHEMBL8595671 0.84 ACHE (0.54) ACHEMETAP1CYP19A1HTR2AHTR2C
SCHEMBL5951282 0.82 CYP19A1 (0.38) ACHEMETAP1CYP19A1AADATALDH1A1
SCHEMBL7627859 0.81 ACHE (0.62) ACHEMETAP1CYP19A1HTR2AHTR2C
SCHEMBL24209598 0.79 CYP19A1 (0.36) ACHEMETAP1CYP19A1ALDH1A1CA1
SCHEMBL19357479 0.79 SIRT2 (0.35) ACHEMETAP1
SCHEMBL3718760 0.77 THRA (0.39) METAP1CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008115141-A1 4, 5-DIHYDRO-1,3-THIAZOL-2-AMINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF RESPIRATORY, CARDIOVASCULAR, NEUROLOGICAL OR GASTROINTESTINAL DISORDERS ALBIREO AB (SE) 2008-09-25 WO disclosed